The Ongoing Evolution of Liver Transplantation in Alcohol‐Associated Liver Disease
John P. Rice – 24 October 2020
The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States
Lisa M. Nyberg, T. Craig Cheetham, Heather M. Patton, Su‐Jau Yang, Kevin M. Chiang, Susan L. Caparosa, Julie A. Stern, Anders H. Nyberg – 24 October 2020 – Nonalcoholic fatty liver disease (NAFLD) is a global public health problem. However, the natural history of NAFLD is incomplete. This is a retrospective cohort study of patients identified with NAFLD by diagnosis codes in a large, community‐based health care delivery system.
Expanding the Scope of Donation After Circulatory Death Liver Transplantation
Peter J. Friend, Fungai Dengu – 24 October 2020
Issue Information
23 October 2020
Issue Information ‐ Instructions to Authors
23 October 2020
Hepatocyte Nuclear Factor 4α Prevents the Steatosis‐to‐NASH Progression by Regulating p53 and Bile Acid Signaling (in mice)
Yanyong Xu, Yingdong Zhu, Shuwei Hu, Yang Xu, Diane Stroup, Xiaoli Pan, Fathima Cassim Bawa, Shaoru Chen, Raja Gopoju, Liya Yin, Yanqiao Zhang – 23 October 2020
Issue Information ‐ Author Checklist
23 October 2020
Issue Information
23 October 2020
Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases
Joseph C. Ahn, Alistair Connell, Douglas A. Simonetto, Cian Hughes, Vijay H. Shah – 23 October 2020 – Modern medical care produces large volumes of multimodal patient data, which many clinicians struggle to process and synthesize into actionable knowledge. In recent years, artificial intelligence (AI) has emerged as an effective tool in this regard. The field of hepatology is no exception, with a growing number of studies published that apply AI techniques to the diagnosis and treatment of liver diseases.
Issue Information
23 October 2020